Biosimilar and Originator Product in Inflammatory Bowel Diseases: Mind the Gap?
2019-01-01 Kotze, Pg; Danese, S
Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting
2017-01-01 Martelli, L; Lopez, A; Strobel, S; Danese, S; Roblin, X; Baumann, C; Peyrin-Biroulet, L
Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for Crohn's disease : results from the MULTIPER database
2015-01-01 Kotze, P. G.; Yamamoto, T.; Danese, S.; Suzuki, Y.; Teixeira, F. V.; de Albuquerque, I. C.; Saad-Hossne, R.; de Barcelos, I. F.; da Silva, R. N.; Kotze, L. M. D. S.; Olandoski, M.; Sacchi, M.; Yamada, A.; Takeuchi, K.; Spinelli, A.
Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment
2020-01-01 Le Berre, C; Ananthakrishnan, An; Danese, S; Singh, S; Peyrin-Biroulet, L
Galectin-4 Controls Intestinal Inflammation by Selective Regulation of Peripheral and Mucosal T Cell Apoptosis and Cell Cycle
2008-01-01 Paclik, D; Danese, S; Berndt, U; Wiedenmann, B; Dignass, A; Sturm, A
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases
2004-01-01 Saibeni, S; Bottasso, B; Spina, L; Bajetta, M; Danese, S; Gasbarrini, A; De Franchis, R; Vecchi, M
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
2010-01-01 Allez, M; Karmiris, K; Louis, E; Van Assche, G; Ben-Horin, S; Klein, A; Van Der Woude, J; Baert, F; Eliakim, R; Katsanos, K; Brynskov, J; Steinwurz, F; Danese, S; Vermeire, S; Teillaud, Jl; Lemann, M; Chowers, Y
Immune and nonimmune components orchestrate the pathogenesis of inflammatory bowel disease
2011-01-01 Danese, S
Colorectal cancer screening: dying en route?
2010-01-01 Danese, S.; Laghi, L.; Repici, A.; Malesci, A.
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study
2016-01-01 Fiorino, G; Cortes, Pn; Ellul, P; Felice, C; Karatzas, P; Silva, M; Lakatos, Pl; Bossa, F; Ungar, B; Sebastian, S; Furfaro, F; Karmiris, K; Katsanos, Kh; Muscat, M; Christodoulou, Dk; Maconi, G; Kopylov, U; Magro, F; Mantzaris, Gj; Armuzzi, A; Bosca-Watts, Mm; Ben-Horin, S; Bonovas, S; Danese, S
Laparoscopic Surgery for Recurrent Crohn's Disease
2012-01-01 Spinelli, A; Sacchi, M; Bazzi, P; Leone, N; Danese, S; Montorsi, M
The Role of JAM-A in Inflammatory Bowel Disease: Unrevealing the Ties That Bind
2009-01-01 Vetrano, S; Danese, S
Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2016-01-01 Bonovas, S; Fiorino, G; Allocca, M; Lytras, T; Tsantes, A; Peyrin-Biroulet, L; Danese, S
Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus
2019-01-01 Daperno, M; Armuzzi, A; Danese, S; Fries, W; Liguori, G; Orlando, A; Papi, C; Principi, M; Rizzello, F; Viscido, A; Gionchetti, P
Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients
2003-01-01 Danese, S; De La Motte, C; Sturm, A; Vogel, Jd; West, Ga; Strong, Sa; Katz, Ja; Fiocchi, C
Drug development in IBD: from novel target identification to early clinical trials
2016-01-01 Danese, S; Fiocchi, C; Panes, J
New therapeutic avenues in ulcerative colitis: thinking out of the box
2013-01-01 Torres, J; Danese, S; Colombel, Jf
Novel therapeutic targets for inflammatory bowel disease
2017-01-01 Argollo, M; Fiorino, G; Hindryckx, P; Peyrin-Biroulet, L; Danese, S
Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease
2014-01-01 Cesarini, M; Danese, S
Comparison of two methods for the in-vivo diagnosis of Helicobacter pylori infection using a tablet of C-13-urea
2017-01-01 Gilardi, D; Fiorino, G; Furfaro, F; Alfieri, Mf; Orlandi, I; Allocca, M; Danese, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Biosimilar and Originator Product in Inflammatory Bowel Diseases: Mind the Gap? | 1-gen-2019 | Kotze, Pg; Danese, S | |
| Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting | 1-gen-2017 | Martelli, L; Lopez, A; Strobel, S; Danese, S; Roblin, X; Baumann, C; Peyrin-Biroulet, L | |
| Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for Crohn's disease : results from the MULTIPER database | 1-gen-2015 | Kotze, P. G.; Yamamoto, T.; Danese, S.; Suzuki, Y.; Teixeira, F. V.; de Albuquerque, I. C.; Saad-Hossne, R.; de Barcelos, I. F.; da Silva, R. N.; Kotze, L. M. D. S.; Olandoski, M.; Sacchi, M.; Yamada, A.; Takeuchi, K.; Spinelli, A. | |
| Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment | 1-gen-2020 | Le Berre, C; Ananthakrishnan, An; Danese, S; Singh, S; Peyrin-Biroulet, L | |
| Galectin-4 Controls Intestinal Inflammation by Selective Regulation of Peripheral and Mucosal T Cell Apoptosis and Cell Cycle | 1-gen-2008 | Paclik, D; Danese, S; Berndt, U; Wiedenmann, B; Dignass, A; Sturm, A | |
| Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases | 1-gen-2004 | Saibeni, S; Bottasso, B; Spina, L; Bajetta, M; Danese, S; Gasbarrini, A; De Franchis, R; Vecchi, M | |
| Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects | 1-gen-2010 | Allez, M; Karmiris, K; Louis, E; Van Assche, G; Ben-Horin, S; Klein, A; Van Der Woude, J; Baert, F; Eliakim, R; Katsanos, K; Brynskov, J; Steinwurz, F; Danese, S; Vermeire, S; Teillaud, Jl; Lemann, M; Chowers, Y | |
| Immune and nonimmune components orchestrate the pathogenesis of inflammatory bowel disease | 1-gen-2011 | Danese, S | |
| Colorectal cancer screening: dying en route? | 1-gen-2010 | Danese, S.; Laghi, L.; Repici, A.; Malesci, A. | |
| Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study | 1-gen-2016 | Fiorino, G; Cortes, Pn; Ellul, P; Felice, C; Karatzas, P; Silva, M; Lakatos, Pl; Bossa, F; Ungar, B; Sebastian, S; Furfaro, F; Karmiris, K; Katsanos, Kh; Muscat, M; Christodoulou, Dk; Maconi, G; Kopylov, U; Magro, F; Mantzaris, Gj; Armuzzi, A; Bosca-Watts, Mm; Ben-Horin, S; Bonovas, S; Danese, S | |
| Laparoscopic Surgery for Recurrent Crohn's Disease | 1-gen-2012 | Spinelli, A; Sacchi, M; Bazzi, P; Leone, N; Danese, S; Montorsi, M | |
| The Role of JAM-A in Inflammatory Bowel Disease: Unrevealing the Ties That Bind | 1-gen-2009 | Vetrano, S; Danese, S | |
| Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease A Systematic Review and Meta-Analysis of Randomized Controlled Trials | 1-gen-2016 | Bonovas, S; Fiorino, G; Allocca, M; Lytras, T; Tsantes, A; Peyrin-Biroulet, L; Danese, S | |
| Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus | 1-gen-2019 | Daperno, M; Armuzzi, A; Danese, S; Fries, W; Liguori, G; Orlando, A; Papi, C; Principi, M; Rizzello, F; Viscido, A; Gionchetti, P | |
| Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients | 1-gen-2003 | Danese, S; De La Motte, C; Sturm, A; Vogel, Jd; West, Ga; Strong, Sa; Katz, Ja; Fiocchi, C | |
| Drug development in IBD: from novel target identification to early clinical trials | 1-gen-2016 | Danese, S; Fiocchi, C; Panes, J | |
| New therapeutic avenues in ulcerative colitis: thinking out of the box | 1-gen-2013 | Torres, J; Danese, S; Colombel, Jf | |
| Novel therapeutic targets for inflammatory bowel disease | 1-gen-2017 | Argollo, M; Fiorino, G; Hindryckx, P; Peyrin-Biroulet, L; Danese, S | |
| Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease | 1-gen-2014 | Cesarini, M; Danese, S | |
| Comparison of two methods for the in-vivo diagnosis of Helicobacter pylori infection using a tablet of C-13-urea | 1-gen-2017 | Gilardi, D; Fiorino, G; Furfaro, F; Alfieri, Mf; Orlandi, I; Allocca, M; Danese, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista40134
Data di pubblicazione
- In corso di stampa9
- 2020 - 202712186
- 2010 - 201915980
- 2000 - 20097460
- 1990 - 19993486
- 1980 - 1989935
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.823
- Elsevier B.V.809
- Springer Science and Business Med...552
- John Wiley and Sons Inc549
- Oxford University Press506
- Lippincott Williams and Wilkins435
- Springer374
- Elsevier Ltd350
- MDPI348
- Springer Nature296
Rivista
- EUROPEAN UROLOGY535
- BLOOD372
- PLOS ONE313
- JOURNAL OF NEUROLOGY291
- EUROPEAN JOURNAL OF HEART FAILURE281
- NEUROLOGY270
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL225
- MULTIPLE SCLEROSIS219
- SCIENTIFIC REPORTS215
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19636
- Retrospective Studies628
- Treatment Outcome603
- Prognosis483
Lingua
- eng29490
- ita1971
- fre65
- und55
- spa34
- ger26
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext32003
- reserved4297
- open3722
- partially open104
- embargoed7
- mixed1